Lateral septum adenosine A 2A receptors control stress-induced depressive-like behaviors via signaling to the hypothalamus and habenula
Major depressive disorder ranks as a major burden of disease worldwide, yet the current antidepressant medications are limited by frequent non-responsiveness and significant side effects. The lateral septum (LS) is thought to control of depression, however, the cellular and circuit substrates are la...
Gespeichert in:
Veröffentlicht in: | Nature communications 2023-04, Vol.14 (1), p.1880 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Major depressive disorder ranks as a major burden of disease worldwide, yet the current antidepressant medications are limited by frequent non-responsiveness and significant side effects. The lateral septum (LS) is thought to control of depression, however, the cellular and circuit substrates are largely unknown. Here, we identified a subpopulation of LS GABAergic adenosine A
receptors (A
R)-positive neurons mediating depressive symptoms via direct projects to the lateral habenula (LHb) and the dorsomedial hypothalamus (DMH). Activation of A
R in the LS augmented the spiking frequency of A
R-positive neurons leading to a decreased activation of surrounding neurons and the bi-directional manipulation of LS-A
R activity demonstrated that LS-A
Rs are necessary and sufficient to trigger depressive phenotypes. Thus, the optogenetic modulation (stimulation or inhibition) of LS-A
R-positive neuronal activity or LS-A
R-positive neurons projection terminals to the LHb or DMH, phenocopied depressive behaviors. Moreover, A
R are upregulated in the LS in two male mouse models of repeated stress-induced depression. This identification that aberrantly increased A
R signaling in the LS is a critical upstream regulator of repeated stress-induced depressive-like behaviors provides a neurophysiological and circuit-based justification of the antidepressant potential of A
R antagonists, prompting their clinical translation. |
---|---|
ISSN: | 2041-1723 |
DOI: | 10.1038/s41467-023-37601-x |